HELP
Sign In
Quick Links
MindSpec
AutDB Home
Human Gene
Animal Models
PIN
CNV
Reading Room
TOOLS
Advanced Search
User guide
Submit New Gene
Workspace
Pending Updates
Z_CNTNAP2A_1_DM_HM_RISPERIDONE/0.001UM
Model Details
Change
No Change
Phenotypic Profile
Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Circadian sleep/wake cycle
Locomotor activity in diurnal cycle
1
Side effect
View More
Description:
Treatment with 0.001 uM risperidone changed the rest-wake activity cycle, such as average activity at night or while awake, in treated zebrafish mutants.
General observations
5 dpf; 6dpf
Description:
Treatment with 0.001 uM risperidone changed the rest-wake activity cycle, such as average activity at night or while awake, in treated zebrafish mutants.
Motor phenotype
Hyperactivity
1
Restored
View More
Description:
Treatment with 0.001 uM risperidone restored nighttime hyperactivity in cntnap2ab mutants.
General observations
5 dpf
Description:
Treatment with 0.001 uM risperidone restored nighttime hyperactivity in cntnap2ab mutants.
Not Reported:
Communications
,
Developmental profile
,
Emotion
,
Immune response
,
Learning & memory
,
Maternal behavior
,
Molecular profile
,
Neuroanatomy / ultrastructure / cytoarchitecture
,
Neurophysiology
,
Physiological parameters
,
Repetitive behavior
,
Seizure
,
Sensory
,
Social behavior
,
References:
1:
Hoffman EJ , et al. 2016
HELP
Copyright © 2017 MindSpec, Inc.
